Prnp knockdown in transgenic mice using RNA interference

Micaela Gallozzi1, Jérome Chapuis, Fabienne Le Provost

  • 1UR 339, Laboratoire de Génétique Biochimique et de Cytogénétique, Institut National de la Recherche Agronomique, 78350, Jouy-en-Josas, France.

Transgenic Research
|March 20, 2008
PubMed

Insights

RNA interference effectively reduced prion protein gene expression in mice. This gene knockdown approach shows promise for disease resistance, though expression levels impact efficiency.

Area of Science:

  • Molecular Biology
  • Genetics
  • Neuroscience

Background:

  • RNA interference (RNAi) is a powerful tool for gene knockdown in various organisms.
  • The prion protein (PrP) is implicated in neurodegenerative diseases.

Purpose of the Study:

  • To develop and test an RNA interference strategy targeting the prion protein mRNA.
  • To assess the efficacy of this approach in reducing endogenous Prnp gene expression in transgenic mice.

Main Methods:

  • Designed a microRNA (miRNA) targeting prion protein mRNA.
  • Expressed the miRNA using the human PRNP promoter in cell cultures and transgenic mice.
  • Quantified Prnp gene expression levels in transfected cells and mouse lines.

Main Results:

  • Confirmed miRNA efficiency in transfected cells.
  • Generated several transgenic mouse lines expressing the designed miRNA.
  • Observed significant downregulation of endogenous mouse Prnp gene expression, up to 80% inhibition.
  • Found a correlation between transgene expression level and Prnp gene downregulation.

Conclusions:

  • RNA interference is a viable strategy for targeting Prnp gene expression.
  • The efficiency of RNAi-mediated gene knockdown is dependent on transgene expression levels.
  • This approach holds potential for developing disease resistance strategies against prion diseases, with noted limitations.